最後更新 2024-11-21 16:27:27 (UTC+8)

基本分析

透過季節調整季營收,判斷美股整體趨勢,但注意股價有時候領先基本面的數據,應搭配其他領先指標判斷。

季營收趨勢 tooltip

季節調整季營收
季增率

0.6%


截至2024-09-30

基本資料

個股的基本資料,以及所屬的類股和產業。

公司介紹

業務介紹

生物技術公司及其子公司在全球範圍內開發、製造和銷售生命科學試劑、儀器和服務,用於研究和臨床診斷市場。該公司通過蛋白質科學和診斷與基因組兩個業務部門運營。

蛋白質科學部門開發和製造用於生命科學研究、診斷以及細胞和基因療法各個方面的生物試劑,如細胞因子和生長因子、抗體、小分子、組織培養血清和細胞篩選技術。該部門還提供自動化Western Blot和多重ELISA工作流程的蛋白質分析工具,包括手動和自動化的蛋白質分析儀器和免疫分析,用於量化各種生物液體中的蛋白質。

診斷與基因組部門開發和製造診斷產品,包括用於監管診斷市場的對照品、校準劑和診斷試劑,基於外泌體的分子診斷分析,用於空間基因組和組織活檢分析的先進組織原位雜交分析,以及用於研究和臨床應用的遺傳和腫瘤學套件;並銷售用於遺傳載體篩查、腫瘤診斷、分子對照和研究的產品,以及用於血液學、血液化學和氣體、凝血對照和試劑的儀器和過程控制產品,用於各種診斷應用。

該公司的產品以R&D Systems、Tocris Biosciences、Novus Biologicals、ProteinSimple、Advanced Cell Diagnostics、Exosome Diagnostics和Asuragen品牌銷售。該公司原名為Techne Corporation,於2014年11月更名為Bio-Techne Corporation。該公司成立於1976年,總部位於明尼蘇達州明尼阿波利斯。



Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. It offers its products under R&D Systems, Tocris Biosciences, Novus Biologicals, ProteinSimple, Advanced Cell Diagnostics, Exosome Diagnostics, and Asuragen brands. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was founded in 1976 and is headquartered in Minneapolis, Minnesota.

所屬產業

所屬類股
Healthcare
所屬產業
Biotechnology

警語

1. 資料僅供參考,不做任何獲利保證及特定股票與點位推薦建議。

2. 資料並不完整,需要完整資料請至相關網站索取。

3. 任何股市數據分析皆存在倖存者偏差。

warning